Impact of Dairy Integration Into Canadian Food Guide on Gut Health

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-65
SponsorLaval University

About this trial

The primary objective is to investigate the impact of milk, fermented milk, and soy beverages, incorporated in a diet reflecting adherence to Canadian food guide recommendations on food choices on gut microbiota in middle-aged adults (45-65 years) with abdominal obesity and slightly deteriorated lipids and/or glucose profile. The study aims to discern whether the integration of soy beverages (control), milk, and fermented milk within the CFG diet contributes to distinct gut outcomes and alterations in gut health. We hypothesized that milk and fermented milk will further promote beneficial changes in gut health parameters including gut microbiota composition, trans-epithelial permeability, and inflammation, relative to soy beverages.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

IMC < 45

Waist circumference > 80 cm (Women) or 94 cm (men)

Disqualifiers

History of diabetes (types 1 and 2), CVD, enteropathy, immune diseases or bariatric surgery

Cancer (diagnostic and/or treatment) during the last 5 years

Antibiotic consumption during the last 3 months

Active smoking or cannabis consumption

Trial design

Design model

Crossover

Treatments tested in this trial

  • Milk

    Other intervention

    Consumption of 1 cup milk 3 times per day during 9 days alongside CFG diet

  • Fermented milk

    Other intervention

    Consumption of fermented milk 3 times per day during 9 days alongside CFG diet

  • Soy beverage

    Other intervention

    Consumption of a soy beverage 3 times per day during 9 days alongside CFG diet

Treatment groups

20 Participants
are divided into 3 treatment groups
Group A: MilkExperimental treatment 3 interventions
Group B: Fermented milkExperimental treatment 3 interventions
Group C: Soy beverageExperimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

Gut epithelial permeability

Post-intervention lactulose/mannitol ratio by LCMS, 0-5 hours after ingestion of the non-metabolizable sugar

Time frame
This outcome will be measured on the last day (day 13) of each intervention phase.

Secondary outcomes

1

Gut inflammatory markers

Fecal calprotectin levels by ELISA

Time frame
Samples will be collected on days 6 and 13 of each intervention phase.
2

Perceived gut symptoms

Perception gastrointestinal symptoms questionnaires

Time frame
Gastrointestinal symptoms questionnaire is administered on days 0, 4 and 13.
3

Whole gut transit time

Whole gut transit time (h) by the Blue poop challenge

Time frame
At days 1, 4 and 11.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.